| Gene symbol | LAMP3 | Synonyms | CD208, DC LAMP, DC-LAMP, DCLAMP, LAMP, LAMP-3, TSC403 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q27.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | lysosomal associated membrane protein 3 | ||||
| Gene symbol | UL83 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_006273.2 | dbXrefs | |
| Description | tegument protein pp65 | ||||
| GTO ID | GTC1288 |
| Trial ID | NCT00626483 |
| Disease | Malignant Neoplasm |
| Altered gene | UL83|LAMP |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | CMV pp65-LAMP mRNA-loaded DC Vaccine |
| Co-treatment | basiliximab |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | REGULATory T-Cell Inhibition With Basiliximab (Simulect) During Recovery From Therapeutic Temozolomide-induced Lymphopenia During Antitumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme |
| Year | 2007 |
| Country | United States |
| Company sponsor | Gary Archer Ph.D. |
| Other ID(s) | Pro00000581|P50CA108786|P30CA014236|SPORE Project 3|CDR0000579683 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||